Evfm sec
WebDec 31, 2024 · The aggregate market value of the common stock held by non‑affiliates of the registrant was approximately $ 190,546,003 as of June 30, 2024, based upon the closing sale price on the Nasdaq Capital … WebSEC Home » Search the Next ... evfm-20240405_pre.xml: EX-101.PRE: 22355: 6: EXTRACTED XBRL INSTANCE DOCUMENT: form8-ka_htm.xml: XML: 3625: Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 . Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900.
Evfm sec
Did you know?
WebMar 21, 2024 · SAN DIEGO, March 21, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced it has implemented measures to lower its operating expenses, with the goal of ... WebApr 10, 2024 · Ticker: EVFM CIK: 1618835 Form Type: 8-K Corporate News Accession Number: 0001493152-23-011771 Submitted to the SEC: Mon Apr 10 2024 5:26:12 PM EST Accepted by the SEC: Mon Apr 10 2024 Period: Wednesday, April 5, 2024 Industry: Pharmaceutical Preparations Events: Event for Officers; Financial Exhibit; New …
WebEVFM Profile. Company Profile. Evofem Biosciences Inc. 12400 High Bluff Drive. ... Alexander A. Fitzpatrick General Counsel and Secretary: Derivative/Non-derivative $0.86 PER SHARE: 42,120 $36,223 ... Web2 days ago · 0001618835 2024-04-05 2024-04-05 iso4217:USD xbrli:shares
WebEvofem Biosciences Inc. (EVFM) sec form 4 filings insider trading, insiders stock buying and selling. WebAug 4, 2024 · Evofem Biosciences, Inc., (Nasdaq: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and six-month periods ended June 30, 2024 and affirmed full-year 2024 guidance.
WebApr 11, 2024 · A high-level overview of Evofem Biosciences, Inc. (EVFM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebApr 11, 2024 · 4 brokerages have issued twelve-month target prices for Evofem Biosciences' stock. Their EVFM share price forecasts range from $3.50 to $8.55. On average, they anticipate the company's stock price to reach $5.35 in the next year. This suggests a possible upside of 24,273.6% from the stock's current price. View analysts … jean gabin filmografiaWebUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2024 EVOFEM BIOSCIENCES, INC. jean gabin dog actorWebMay 20, 2024 · Evofem Biosciences Announces Pricing of Approximately $26.6 Million Public Offering. SAN DIEGO, May 20, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced … labette bank columbus kansasWebMar 15, 2024 · About SEC Filings. Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and … jean gabin je saisWebApr 10, 2024 · 0001618835 2024-04-05 2024-04-05 iso4217:USD xbrli:shares iso4217:USD jean gabin maintenant je sais traduzione italianoWebDec 30, 2024 · Ticker: EVFM CIK: 1618835 Form Type: 8-K Corporate News Accession Number: 0001618835-22-000212 Submitted to the SEC: Fri Dec 30 2024 9:25:03 AM EST Accepted by the SEC: Fri Dec 30 2024 Period: Thursday, December 29, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … la betulia liberataWebMar 10, 2024 · SAN DIEGO, March 3, 2024 - Evofem Biosciences, Inc. (Nasdaq: EVFM), a commercial stage biopharmaceutical company, today reported financial results for the … la betulia liberata text